Analysis of tumor data showed that women with Stage IV were more likely to have larger tumors, non-ductal or lobular undifferentiated histologies (“Other”), negative ER or PR status, positive Her2 status, LVI, and poorly differentiated grade. The gene discussed is ESR1; the disease is neoplasm.